A novel oral therapy that inhibits the interleukin-23 inflammatory pathway provided control of moderate-to-severe psoriasis ...
For example, after experiencing significant fatigue walking through a stadium to attend her daughter's cheerleading competition — which required a week of recuperation afterwards — Ayesha began to ...
Icotrokinra demonstrated clinically meaningful outcomes at Week 28 in the Phase 2b ANTHEM-UC study in ulcerative colitis, with 31.7% of patients achieving clinical remission and 38.1% showing ...
NAILS: The inflammation throughout the body from PsA and PsO can affect the nail beds as well. The symptoms can range from minor nail weakening and swelling of the nail bed to pitting (dents on the ...
They may be far away from your major organs, but your feet can hold major clues about your health — especially if you’re ...
Psoriasis isn't just a skin condition. It's an autoimmune disease that can shape your mental and emotional world too.
Icotrokinra demonstrated clinically meaningful outcomes at Week 28 in the Phase 2b ANTHEM-UC study in ulcerative colitis, with 31.7% of patients achieving clinical remission and 38.1% showing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results